Bristol Myers Squibb picked Houston. The announcement landed August 10, 2026: a $2.3 billion manufacturing campus of roughly 600,000 square feet at Generation Park, the 4,300-acre development northeast of downtown, with construction starting in 2027 and running to 2030.
Project Scope
The design premise is flexibility rather than a single product line. BMS has described the campus as multi-modal, configured to make small molecules, biologics and antibody-drug conjugates on one site, with the production footprint meant to be re-proportioned as the pipeline shifts. That’s a harder brief than a dedicated plant. Small-molecule synthesis, mammalian cell culture and high-containment conjugation carry different containment classes, different utility loads and different regulatory documentation, and putting them on a shared campus means designing for the strictest case in the shared systems.
Roughly 500 permanent jobs follow, against about 2,000 construction workers sustained through 2030. McCord Development is the master developer at Generation Park. BMS has not named an architect or general contractor.
Texas put $4.89 million from the Texas Enterprise Fund toward the deal, with eligibility under the state’s JETI program on top.
Why It Matters
It’s part of a $40 billion, five-year U.S. investment commitment from BMS, and it makes Generation Park a two-anchor pharma cluster — Eli Lilly is already building an API facility in the same business park. Two competitors drawing from the same regional trade base at the same time is the kind of thing that moves labor rates.
The construction ramp is the number worth holding onto. Roughly 2,000 trade workers, sustained for three years, before a single batch runs. Houston’s industrial contractors have the mechanical and process depth to staff it, but the pharma-grade documentation and validation work is a different discipline from petrochemical, and the firms that can do both are a short list.
Announced August 10, this is one of the freshest large U.S. industrial site selections on the board.
Project Team & Details
| Developer | McCord Development (Generation Park master developer) |
|---|
| Owner / Client | Bristol Myers Squibb |
|---|
| Status | Planned |
|---|
| Funding Source | Private |
|---|